A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

Background: The recommended booster third dose of vaccination against COVID-19 in cancer patients seems reasonable to protect them against a severe disease course. A prospective study was designed to assess the immunogenicity, efficacy, and safety of COVID-19 vaccination in this cohort. Methods: Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Janzic, Urska, Bidovec-Stojkovic, Urska, Korosec, Peter, Mohorcic, Katja, Mrak, Loredana, Caks, Marina, Ravnik, Maja, Skof, Erik, Rijavec, Matija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301109/
https://www.ncbi.nlm.nih.gov/pubmed/37376406
http://dx.doi.org/10.3390/vaccines11061017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301109/
https://www.ncbi.nlm.nih.gov/pubmed/37376406
http://dx.doi.org/10.3390/vaccines11061017

Ejemplares similares